{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:03:31Z","timestamp":1772136211658,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-69003-4","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T11:03:05Z","timestamp":1723201385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Improved thermal stabilization of VSV-vector with enhanced vacuum drying in pullulan and trehalose-based films"],"prefix":"10.1038","volume":"14","author":[{"given":"Jeremy A.","family":"Iwashkiw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulhamid O.","family":"Mohamud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natallia","family":"Kazhdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaisha","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody E.","family":"Beecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos D. M.","family":"Filipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Lichty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"issue":"16","key":"69003_CR1","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1073\/pnas.1704507114","volume":"114","author":"WA Orenstein","year":"2017","unstructured":"Orenstein, W. A. & Ahmed, R. Simply put: Vaccination saves lives. Proc. Natl. Acad. Sci. USA 114(16), 4031\u20134033 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1645","key":"69003_CR2","doi-asserted-by":"publisher","first-page":"20130426","DOI":"10.1098\/rstb.2013.0426","volume":"369","author":"C Dye","year":"2014","unstructured":"Dye, C. After 2015: Infectious diseases in a new era of health and development. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369(1645), 20130426 (2014).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"69003_CR3","doi-asserted-by":"publisher","first-page":"13520","DOI":"10.1038\/ncomms13520","volume":"7","author":"M Pelliccia","year":"2016","unstructured":"Pelliccia, M. et al. Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months. Nat. Commun. 7, 13520 (2016).","journal-title":"Nat. Commun."},{"key":"69003_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2021.100119","volume":"9","author":"S Jarrett","year":"2021","unstructured":"Jarrett, S. et al. The importance of vaccine stockpiling to respond to epidemics and remediate global supply shortages affecting immunization: Strategic challenges and risks identified by manufacturers. Vaccine X 9, 100119 (2021).","journal-title":"Vaccine X"},{"key":"69003_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114313","volume":"187","author":"Z Ghaemmaghamian","year":"2022","unstructured":"Ghaemmaghamian, Z. et al. Stabilizing vaccines via drying: Quality by design considerations. Adv. Drug Deliv. Rev. 187, 114313 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"69003_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1021\/js980374e","volume":"88","author":"MC Lai","year":"1999","unstructured":"Lai, M. C. & Topp, E. M. Solid-state chemical stability of proteins and peptides. J. Pharm. Sci. 88(5), 489\u2013500 (1999).","journal-title":"J. Pharm. Sci."},{"key":"69003_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ejpb.2017.01.024","volume":"114","author":"MA Mensink","year":"2017","unstructured":"Mensink, M. A. et al. How sugars protect proteins in the solid state and during drying (review): Mechanisms of stabilization in relation to stress conditions. Eur. J. Pharm. Biopharm. 114, 288\u2013295 (2017).","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"69003_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/14760584.2021.1902314","volume":"20","author":"Y Qi","year":"2021","unstructured":"Qi, Y. & Fox, C. B. Development of thermostable vaccine adjuvants. Expert Rev. Vaccines 20(5), 497\u2013517 (2021).","journal-title":"Expert Rev. Vaccines"},{"issue":"3","key":"69003_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/pharmaceutics10030131","volume":"10","author":"F Emami","year":"2018","unstructured":"Emami, F. et al. Drying technologies for the stability and bioavailability of biopharmaceuticals. Pharmaceutics 10(3), 131 (2018).","journal-title":"Pharmaceutics"},{"issue":"2","key":"69003_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/0250-474X.103837","volume":"74","author":"RD Jangle","year":"2012","unstructured":"Jangle, R. D. & Pisal, S. S. Vacuum foam drying: An alternative to lyophilization for biomolecule preservation. Indian J. Pharm. Sci. 74(2), 91\u2013100 (2012).","journal-title":"Indian J. Pharm. Sci."},{"issue":"9","key":"69003_CR11","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/jps.23998","volume":"103","author":"RH Walters","year":"2014","unstructured":"Walters, R. H. et al. Next generation drying technologies for pharmaceutical applications. J. Pharm. Sci. 103(9), 2673\u20132695 (2014).","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"69003_CR12","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1080\/21645515.2019.1649532","volume":"15","author":"A Fathi","year":"2019","unstructured":"Fathi, A., Dahlke, C. & Addo, M. M. Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens. Hum. Vaccin. Immunother. 15(10), 2269\u20132285 (2019).","journal-title":"Hum. Vaccin. Immunother."},{"issue":"6249","key":"69003_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.aab3920","volume":"349","author":"A Marzi","year":"2015","unstructured":"Marzi, A. et al. EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain. Science 349(6249), 739\u2013742 (2015).","journal-title":"Science"},{"issue":"4","key":"69003_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003736","volume":"9","author":"D Safronetz","year":"2015","unstructured":"Safronetz, D. et al. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. PLoS Negl. Trop. Dis. 9(4), e0003736 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"69003_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/v10020090","volume":"10","author":"S Bishnoi","year":"2018","unstructured":"Bishnoi, S. et al. Oncotargeting by vesicular stomatitis virus (VSV): Advances in cancer therapy. Viruses 10(2), 90 (2018).","journal-title":"Viruses"},{"key":"69003_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2019.100009","volume":"1","author":"TP Monath","year":"2019","unstructured":"Monath, T. P. et al. rVSVDeltaG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk\/benefit assessment. Vaccine X 1, 100009 (2019).","journal-title":"Vaccine X"},{"key":"69003_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.coviro.2016.03.008","volume":"17","author":"AM Henao-Restrepo","year":"2016","unstructured":"Henao-Restrepo, A. M. et al. On a path to accelerate access to Ebola vaccines: The WHO\u2019s research and development efforts during the 2014\u20132016 Ebola epidemic in West Africa. Curr. Opin. Virol. 17, 138\u2013144 (2016).","journal-title":"Curr. Opin. Virol."},{"issue":"10068","key":"69003_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","volume":"389","author":"AM Henao-Restrepo","year":"2017","unstructured":"Henao-Restrepo, A. M. et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: Final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!). Lancet 389(10068), 505\u2013518 (2017).","journal-title":"Lancet"},{"key":"69003_CR19","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1473-3099(23)00819-8","volume":"24","author":"RM Coulborn","year":"2024","unstructured":"Coulborn, R. M. et al. Case fatality risk among individuals vaccinated with rVSVDeltaG-ZEBOV-GP: A retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo. Lancet Infect. Dis. 24, 602\u2013610 (2024).","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"69003_CR20","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s11427-022-2230-4","volume":"66","author":"T Li","year":"2023","unstructured":"Li, T. et al. Current progress in the development of prophylactic and therapeutic vaccines. Sci. China Life Sci. 66(4), 679\u2013710 (2023).","journal-title":"Sci. China Life Sci."},{"key":"69003_CR21","unstructured":"Package Insert: ERVEBO (2023)."},{"issue":"1","key":"69003_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44020-w","volume":"9","author":"V Leung","year":"2019","unstructured":"Leung, V. et al. Thermal stabilization of viral vaccines in low-cost sugar films. Sci. Rep. 9(1), 7631 (2019).","journal-title":"Sci. Rep."},{"issue":"1","key":"69003_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70325-2","volume":"10","author":"SP Toniolo","year":"2020","unstructured":"Toniolo, S. P. et al. Spray dried VSV-vectored vaccine is thermally stable and immunologically active in vivo. Sci. Rep. 10(1), 13349 (2020).","journal-title":"Sci. Rep."},{"issue":"11","key":"69003_CR24","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1021\/acsbiomaterials.7b00468","volume":"4","author":"V Leung","year":"2018","unstructured":"Leung, V. et al. Long-term preservation of bacteriophage antimicrobials using sugar glasses. ACS Biomater. Sci. Eng. 4(11), 3802\u20133808 (2018).","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"42","key":"69003_CR25","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1016\/j.vaccine.2015.08.085","volume":"33","author":"LJJ Hansen","year":"2015","unstructured":"Hansen, L. J. J. et al. Freeze-drying of live virus vaccines: A review. Vaccine 33(42), 5507\u20135519 (2015).","journal-title":"Vaccine"},{"key":"69003_CR26","unstructured":"CDC. Expanded Access Investigational New Drug (IND) Protocol: Ervebo\u00ae (Ebola Zaire Vaccine, Live) Booster Dose for Domestic Preexposure Prophylaxis (PrEP) Vaccination of Adults (\u2265 18 years of age) at Potential Occupational Risk for Exposure to Zaire ebolavirus (2022). Available from: https:\/\/www.cdc.gov\/vhf\/ebola\/pdf\/Ebola-Vaccine-Protocol_508.pdf [cited 2024 January 15]."},{"issue":"3","key":"69003_CR27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.xphs.2018.10.039","volume":"108","author":"JW Buecheler","year":"2019","unstructured":"Buecheler, J. W. et al. Oxidation-induced destabilization of model antibody-drug conjugates. J. Pharm. Sci. 108(3), 1236\u20131245 (2019).","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"69003_CR28","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","volume":"92","author":"ND Lawson","year":"1995","unstructured":"Lawson, N. D. et al. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. USA 92(10), 4477\u20134481 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"69003_CR29","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1128\/jvi.70.4.2318-2323.1996","volume":"70","author":"MJ Schnell","year":"1996","unstructured":"Schnell, M. J. et al. The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus. J. Virol. 70(4), 2318\u20132323 (1996).","journal-title":"J. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69003-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69003-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69003-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T11:03:22Z","timestamp":1723201402000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-69003-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["69003"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-69003-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4529092\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18522"}}